Myeloproliferative Disease
📧 Sign up to get email alerts when something new happens for Myeloproliferative Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases [Phase 2]
Phase IIa study of HDAC inhibitor ITF2357 in JAK-2 V617F positive myeloproliferative diseases has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) [Phase 2]
Phase 2 trial of pacritinib before transplantation in myeloproliferative neoplasms was terminated with results posted in 2018.